Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 8/20 | 0.47 |
| ▸ | TLR2 | O60603 | 2/20 | 0.41 |
| ▸ | ACE | P12821 | 1/20 | 0.41 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30053792 | 0.95 | PTPN1 (0.47) | PTPN1TLR2 | |
| SCHEMBL30054217 | 0.88 | CASP3 (0.42) | PTPN1ACE | |
| SCHEMBL31247874 | 0.87 | PTPN1 (0.46) | PTPN1 | |
| SCHEMBL29755484 | 0.87 | PTPN1 (0.55) | PTPN1TLR2ACEMDM2 | |
| SCHEMBL31247891 | 0.86 | PTPN1 (0.44) | PTPN1 | |
| SCHEMBL30054440 | 0.85 | CASP3 (0.49) | PTPN1 | |
| SCHEMBL31247949 | 0.84 | PTPN1 (0.44) | PTPN1 | |
| SCHEMBL29431094 | 0.84 | PTPN1 (0.46) | PTPN1TLR2MDM2 | |
| SCHEMBL30054145 | 0.83 | PTPN1 (0.41) | PTPN1 | |
| SCHEMBL23463320 | 0.82 | PTPN1 (0.46) | PTPN1TLR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230133716-A1 | PREPARATION METHOD FOR SEMAGLUTIDE | Shenzhen JYMed Technology Co., Ltd. (CN) | 2023-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230133716-A1 | PREPARATION METHOD FOR SEMAGLUTIDE | GCG, GLP1R, DPP7 | PTPN1 2050/4885TLR2 3994/4885ACE 1831/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.